MeeshoThe Story
SoftBank sold 8 crore Meesho shares on Thursday for ₹1,650.4 crore, cutting its holding from 8.6 per cent to about 6.87 per cent. The block was placed in two tranches at a weighted average of ₹206.30 a share, a 1.6 per cent discount to that day's close.
The buyers were institutional and largely long-only. Franklin Templeton, Fidelity, Manulife, Motilal Oswal, HDFC Standard Life Insurance, Bajaj Allianz Life, Canara Robeco, Societe Generale, Goldman Sachs Bank Europe, Bank of America Securities and Morgan Stanley were among them.
Meesho shares rose 3.3 per cent the following day to ₹216.67, taking market capitalisation to roughly ₹96,983 crore.
It is the fourth large exit from the company in three months. Fidelity sold a 1.3 per cent stake worth ₹988 crore in June. Elevation Capital and Peak XV together placed 2.3 per cent for ₹1,949 crore. Y Combinator sold 4.9 crore shares for about ₹970 crore in late August. The pre-IPO lock-in expired on 9 June, freeing close to 68 per cent of such shares, worth around ₹60,000 crore.
Meesho listed in December 2025, raising ₹5,421.2 crore at ₹111 a share and opening 46 per cent higher. SoftBank, Prosus and Fidelity all held through the listing.
The business has improved since. First-quarter FY27 operating revenue rose 48 per cent year on year to ₹3,712.8 crore, and net loss narrowed 54 per cent to ₹132.8 crore from ₹289 crore.
SoftBank has been selling across its Indian portfolio. It placed Lenskart shares worth ₹2,887.9 crore in August and ₹2,873.3 crore in June, and cut its Delhivery holding from 9.67 per cent in September 2024 to 7.61 per cent in June.
Why It Matters
The number that matters is not ₹1,650 crore. It is the 3.3 per cent gain the next morning.
A block of that size from the largest pre-IPO backer, placed at a discount, would normally weigh on a stock for days. Meesho absorbed it and traded higher. That is what a functioning exit market looks like, and it is precisely what Indian venture capital has lacked.
Consider what it sits against. Indian private equity and venture capital exit value fell 83 per cent year on year in July, to $1.6 billion, and more than half of that came from secondary sales between financial investors, which returns money to one fund by taking it from another.
This is different in the detail that counts. Look at who bought. Franklin Templeton, Fidelity, Manulife, HDFC Life, Bajaj Allianz, Canara Robeco, Motilal Oswal. Mutual funds and insurers, domestic long-only money alongside global institutions, not other private funds. Venture capital is not circulating here. It is genuinely leaving, into public hands that intend to hold.
In August alone, 17 block and bulk deals across 12 companies moved ₹26,337 crore, about $2.77 billion. That is more in a single month than the entire recorded private exit value in July.
The Strategic Read
Which means the exit route did not close. It moved.
The monthly private-market data showing exits collapsing measures M&A and private secondaries. It does not capture a SoftBank block placed on the NSE at eleven in the morning. Since the IPO window reopened for Indian consumer technology in late 2025, the dominant exit mechanism has shifted from selling a company to selling shares of a listed one, in instalments, to institutions.
That is a healthier arrangement than the one it replaced. It prices continuously rather than once. It lets investors size their exits against real demand. And it puts the buyer's own judgement between the seller and the outcome. Meesho and Lenskart have between them absorbed well over ₹10,000 crore of selling since June, and both trade above where the selling began. That is not luck. Meesho's revenue grew 48 per cent last quarter and its losses halved.
The uncomfortable part is why SoftBank is selling.
It is not because it has soured on Indian consumer internet. It is because it needs capital elsewhere. SoftBank has committed heavily to OpenAI and to Stargate, and its SB Energy subsidiary filed this week for a listing that would move data centre capital expenditure off the parent balance sheet. The Indian portfolio is being liquidated to fund an American AI infrastructure bet.
For Indian founders with SoftBank on the cap table, that is worth sitting with. The selling has nothing to do with performance. Meesho is executing better than it ever has, and its largest early backer is reducing anyway, because a different asset class now offers a better return on the same rupee.
Being sold well is preferable to being sold badly. But a company can be deprioritised by an owner who has simply found something else to do with the money, and no amount of revenue growth changes that arithmetic.
For daily, sharp analysis of the biggest moves in the Indian business and startup ecosystem, follow StartupFox.
